Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.50    7.50 (3.15%)
Bid:
243.00
Ask:
246.00
Spread: 3.00 (1.235%)
Market Cap: £143.22m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Notifiable Interest

5 Nov 2007 11:49

Gleeson(M J)Group PLC05 November 2007 MJ Gleeson Group Plc("the Company") Notifiable Interest A form TR-1 containing the following information has been received by theCompany. TR-1 notification of major interests in shares 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: MJ Gleeson Group Plc 2. Reason for the notification An acquisition or disposal of voting rights 3. Full name of person(s) subject to the notification obligation: Legal & General Group Plc (L&G) 4. Full name of shareholder(s) (if different from 3): Legal & General Assurance (Pensions Management) Limited (PMC) 5. Date of the transaction (and date on which the threshold is crossed orreached if different): 17 October 2007 6. Date on which issuer notified: 02 November 2007 7. Threshold(s) that is/are crossed or reached: From 3% - 4% (L&G) 8. Notified details: A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transactionshares Triggering transaction Notification required under DTR transitional provision 7if possible usingISIN CODE Number of Number of Number of Number of voting rights % of voting rights Shares Voting shares Rights Direct Direct Indirect Direct Indirect ORD 1,782,627 1,782,627 2,155,642 2,155,642 4.12GBP0.02 B: Financial InstrumentsResulting situation after the triggering transaction Type of financial Expiration date Exercise/ Number of voting % of voting rightsinstrument Conversion Period/ rights that may be Date acquired if the instrument is exercised/ converted Total (A+B) Number of voting rights % of voting rights 2,155,642 4.12 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: Legal & General Group Plc (Direct and Indirect) (Group) Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct andIndirect) Legal & General Investment Management Limited (Indirect) (LGIM) Legal & General Group Plc (Direct) (L&G) (2,155,642- 4.12% = LGAS, LGPL & PMC) Legal & General Investment Management (Holdings) Limited Legal & General Insurance Holdings Limited (Direct)(Direct) (LGIMHD) (1,878,121 - 3.59% = PMC) (LGIH) Legal & General Assurance (Pensions Management) Limited Legal & General Assurance Society Limited (LGAS & LGPL)(PMC) (1,878,121 - 3.59% = PMC) Legal & General Pensions Limited (Direct) (LGPL) 10. Name of the Proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: Notification using the total voting rights figure of 52,247,456 Please note this notification has been delayed due to the large number ofdisclosures required following a substantial amount of new business which hascome to us in the form of an in-specie transfer. 14. Contact name: Helen Lewis (LGIM) 15. Contact telephone number: 020 3124 3851 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.